(Q56031907)

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Transthyretin amyloidosis: a new mutation associated with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Secondary glaucoma accompanied with primary familial amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

The molecular biology and clinical features of amyloid neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: A clinicopathologic, histochemical, immunohistochemical, and ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Only amyloidogenic intermediates of transthyretin induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Dimeric transthyretin variant assembles into spherical neurotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Doppler characterization of left ventricular diastolic function in cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Amyloid neuropathy: a retrospective study of 35 peripheral nerve biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Transthyretin oligomers induce calcium influx via voltage-gated calcium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Liver transplantation in transthyretin-related familial amyloid polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Outcome of liver transplantation for familial amyloidotic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Trans-suppression of misfolding in an amyloid disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Prevention of transthyretin amyloid disease by changing protein misfolding energetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Targeted conversion of the transthyretin gene in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Senile Cardiac Amyloidosis: Evidence of Two Different Amyloid Substances in the Ageing Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Fibril in senile systemic amyloidosis is derived from normal transthyretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Senile cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

The premortem recognition of systemic senile amyloidosis with cardiac involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Heart transplantation in a 68-year-old patient with senile systemic amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Liver Transplantation Does Not Prevent the Development of Life-Threatening Arrhythmia in Familial Amyloidotic Polyneuropathy, Portuguese-Type (ATTR Val30Met) Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

The Tetrameric Protein Transthyretin Dissociates to a Non-native Monomer in Solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Tabulation of human transthyretin (TTR) variants, 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36

Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470572702.CH36